PDS Biotechnology Corporation
PDSB
$1.10
-$0.20-15.39%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 26.71M | 26.20M | 31.87M | 39.98M | 41.69M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.54M | 1.69M | 1.77M | 2.49M | 3.36M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 28.25M | 27.89M | 33.65M | 42.47M | 45.05M |
|
|
|||||
| Total Current Assets | 28.25M | 27.89M | 33.65M | 42.47M | 45.05M |
| Net Property, Plant & Equipment | 243.70K | 258.80K | 274.00K | 289.10K | 304.20K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.00M | 6.55M | 6.55M | 4.27M | -- |
| Total Assets | 30.49M | 34.71M | 40.48M | 47.03M | 45.36M |
|
|
|||||
| Total Accounts Payable | 3.57M | 5.18M | 4.50M | 2.86M | 1.68M |
| Total Accrued Expenses | 742.20K | 2.10M | 1.48M | 2.85M | 2.84M |
| Short-term Debt | 5.13M | 6.00M | 5.50M | 12.50M | 12.50M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 36.20K | 44.10K | 51.90K | 59.60K | 61.10K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 9.48M | 13.33M | 11.53M | 18.27M | 17.09M |
|
|
|||||
| Total Current Liabilities | 9.48M | 13.33M | 11.53M | 18.27M | 17.09M |
| Long-Term Debt | 11.73M | 11.89M | 12.94M | 6.35M | 9.20M |
| Short-term Debt | 5.13M | 6.00M | 5.50M | 12.50M | 12.50M |
| Capital Leases | 25.70K | 33.50K | 41.20K | 48.70K | 61.90K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 21.24M | 25.25M | 24.52M | 24.67M | 26.35M |
|
|
|||||
| Common Stock & APIC | 225.86M | 218.50M | 215.99M | 212.96M | 201.12M |
| Retained Earnings | -216.61M | -209.04M | -200.03M | -190.60M | -182.11M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 9.25M | 9.45M | 15.96M | 22.36M | 19.00M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 9.25M | 9.45M | 15.96M | 22.36M | 19.00M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 9.25M | 9.45M | 15.96M | 22.36M | 19.00M |
|
|
|||||